THE ITALIAN GROUP LEADING AN INTERNATIONAL CONSORTIUM TO ENHANCE ONCOLOGICAL DIAGNOSIS AND PREVENTION THROUGH AI, FEDERATED LEARNING AND MEDICAL IMAGING.

THE PROJECT AIMS TO CREATE A FEDERATED NETWORK OF ONCOLOGICAL IMAGING DATA DERIVED FROM SCREENING PROGRAMS FOR BREAST, LUNG AND PROSTATE CANCER. THE GOAL IS TO MAKE DIVERSIFIED AND REPRESENTATIVE DATASETS AVAILABLE FROM ALL OVER EUROPE – INCLUDING GEOGRAPHICAL AREAS CURRENTLY UNDERREPRESENTED – TO ACCELERATE THE DEVELOPMENT OF DIAGNOSTIC SOLUTIONS BASED ON ARTIFICIAL INTELLIGENCE.

FUNDED UNDER THE EU4HEALTH PROGRAM, UNICA INVOLVES 16 PROMINENT PARTNERS, INCLUDING POLITECNICO DI MILANO, UNIVERSITAT POLITÈCNICA DE VALÈNCIA, UNIVERSITY HOSPITAL COLOGNE, UNIVERSITY OF LEIPZIG, ARISTOTLE UNIVERSITY OF THESSALONIKI, KAUNO KLINIKOS (LITHUANIA), WOJEWODZKI SZPITAL IN WROCŁAW (POLAND), MARIBOR HOSPITAL (SLOVENIA) AND NUMEROUS OTHER HOSPITALS, RESEARCH CENTERS AND TECHNOLOGY COMPANIES LOCATED IN EUROPE.

Milan, September 23, 2025 – Datrix, a listed company and the first international ecosystem of Artificial Intelligence software companies, coordinates the European project UNICA (Unified Network for International Cancer Advancement), funded under the EU4Health program, which aims to extend EUCAIM: one of the most strategic initiatives within the European Cancer Imaging Initiative to revolutionize cancer prevention, diagnosis and treatment in Europe.

With a total value of approximately 5 million euros, UNICA is positioned in one of the most promising markets of digital transformation: AI applied to healthcare, which according to major international analyses is already worth tens of billions of euros and is growing at double digits every year. This is a strategic sector, where the adoption of artificial intelligence is destined to generate a decisive impact on the quality of care, the efficiency of health systems and the economic sustainability of the health sector.

The project aims to create a federated network of oncological imaging data derived from screening programs for breast, lung and prostate cancer. The goal is to make diversified and representative datasets available from across Europe — including currently underrepresented geographical areas — to accelerate the development of diagnostic solutions based on Artificial Intelligence.

This project is a concrete application of AI FOR DOING, a sustainable innovation model created by DATRIX and a fundamental aspect of the work the company performs daily, namely the development of vertical AI solutions that generate concrete value, with immediately adoptable applications capable of going into production and having a measurable impact. “Leading UNICA confirms the central role that Datrix is assuming in the European landscape of AI applied to health. Our commitment is to contribute concretely to more predictive, accessible and personalized medicine, enhancing collaboration between clinical centers of excellence, universities and technology companies,” comments Fabrizio Milano d’Aragona, CEO of Datrix.

A European network for innovation in oncological diagnostics

UNICA involves 16 prominent partners, including Politecnico di Milano, Universitat Politècnica de València, University Hospital Cologne, University of Leipzig, Aristotle University of Thessaloniki, Kauno Klinikos (Lithuania), Wojewodzki Szpital in Wrocław (Poland), Maribor Hospital (Slovenia) and numerous other hospitals, research centers and technology companies located in Europe.

The project involves the adoption of advanced AI models for the analysis of medical images, in full compliance with European regulations on privacy, ethics and interoperability. Clinical data, completely anonymized, will be securely shared through a federated infrastructure that promotes European digital sovereignty and the principle of “data altruism.”

Michele Compare, CTO of the Datrix Group, emphasizes: “The technological value of UNICA lies in the creation of a federated infrastructure that allows Artificial Intelligence models to be applied to distributed clinical data without centralizing them. This approach not only guarantees security and respect for privacy but also allows for the best use of AI’s power for more accurate and predictive analysis, benefiting both research and clinical practice.”

Pietro Pinoli, Associate Professor at the Department of Electronics, Information and Bioengineering of the Politecnico di Milano, adds: “From a scientific point of view, UNICA represents a decisive step towards the availability of oncological datasets truly representative of European diversity. Standardizing, integrating and making this information interoperable means creating the ideal conditions for developing advanced and clinically relevant algorithms capable of improving early diagnosis and quality of care.”

A European vision, a global impact

Why is it innovative? To date, most clinical data remains confined within individual hospitals, limiting the impact of scientific research. UNICA overcomes this obstacle through a network of “distributed analysis,” where Artificial Intelligence algorithms are brought to the data without ever moving sensitive information from its place of origin. This model, fully GDPR-compliant, allows for the protection of patient privacy while simultaneously exploiting the wealth of heterogeneous datasets from different countries and contexts.
Unlike traditional approaches based on data centralization and therefore exposed to security risks, UNICA proposes a more sustainable and secure paradigm that accelerates medical research without compromising citizen protection. The result is twofold: on one hand, researchers can rely on larger and more representative databases to better understand risk factors and prevention strategies; on the other hand, European healthcare systems have concrete tools to improve diagnostic accuracy and accelerate the adoption of innovative therapies.

“The fight against cancer is a global priority. At Datrix, we believe that Artificial Intelligence must be a concrete tool at the service of public health and European competitiveness,” concludes Milano d’Aragona.

***

About Datrix

Datrix is a Group listed on Euronext Growth Milan (ISIN code IT00054683), leading the first international ecosystem of B2B vertical software companies powered by Artificial Intelligence.

The Group is active with AI-Based solutions in 2 business areas: AI for Data Monetization (to maximize growth opportunities in the Martech, AdTech and FinTech sectors by transforming data into tangible value) and AI for Industrial & Business Processes (to optimize the efficiency of industrial and business processes in key sectors such as, for example, energy, manufacturing, finance, logistics and transport).

The Datrix Group currently includes the brands: Adapex, Aramix, ByTek, FinScience.

Datrix is also a technological partner to over 20 international universities and research centers for major Research & Development projects (funded by the European Union and Italy) based on Artificial Intelligence algorithms in the LifeScience/Health, Social Well Being, and Cybersecurity fields.

Datrix, with headquarters in Italy, operates in Europe, the United States and the United Arab Emirates.

More info at www. datrixgroup.com

For more information:

Investor Relations: Giuseppe Venezia, tel. +39 0276281064 – ir@datrixgroup.com

Investor Relations Consultant: Francesca Cocco (Lerxi Consulting) – ir@datrixgroup.com

Euronext Growth Advisor: Alantra / Stefano Bellavita, tel. +39 0263671601 – stefano.bellavita@alantra.com

Marketing & Communication: Pierluigi Vacca (CMO Datrix) – pierluigi@datrixgroup.com

Press Office: Dario Ferrante, mob. 3891328130 – dario@miserveunufficiostampa.com